← All trials
NCT05444582
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 7, 2022
- Primary completion
- Mar 31, 2027
- Completion date
- Jul 31, 2027
- First posted
- Jul 6, 2022
- Last posted
- Aug 14, 2023
- Enrollment
- 1404
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of UtahLead sponsor
- Planned ParenthoodCollaborator
- University of UtahOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.